High proportion of drug hypersensitivity reactions to sulfasalazine following its use in anti-PD-1 associated inflammatory arthritis
Research output: Contribution to journal › Article
Authors
Colleges, School and Institutes
External organisations
- University Hospitals Birmingham NHS Foundation Trust
Details
| Original language | English |
|---|---|
| Journal | Rheumatology |
| Early online date | 13 Aug 2018 |
| Publication status | E-pub ahead of print - 13 Aug 2018 |
Keywords
- anti-PD-1, anti-PD-L1, pembrolizumab, melanoma, immune-related adverse event, arthritis